Barclays’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.02M | Buy |
127,113
+43,823
| +53% | +$1.38M | ﹤0.01% | 1773 |
|
|
2025
Q1 | $2.77M | Sell |
83,290
-17,582
| -17% | -$584K | ﹤0.01% | 1815 |
|
|
2024
Q4 | $3.47M | Buy |
100,872
+24,010
| +31% | +$826K | ﹤0.01% | 1846 |
|
|
2024
Q3 | $3.07M | Buy |
76,862
+40,416
| +111% | +$1.62M | ﹤0.01% | 1871 |
|
|
2024
Q2 | $1.1M | Sell |
36,446
-13,498
| -27% | -$407K | ﹤0.01% | 2069 |
|
|
2024
Q1 | $1.68M | Sell |
49,944
-21,314
| -30% | -$715K | ﹤0.01% | 2066 |
|
|
2023
Q4 | $2.3M | Buy |
71,258
+37,069
| +108% | +$1.2M | ﹤0.01% | 2059 |
|
|
2023
Q3 | $1.12M | Buy |
34,189
+4,461
| +15% | +$146K | ﹤0.01% | 2019 |
|
|
2023
Q2 | $1.05M | Buy |
29,728
+750
| +3% | +$26.4K | ﹤0.01% | 2121 |
|
|
2023
Q1 | $946K | Buy |
28,978
+5,719
| +25% | +$187K | ﹤0.01% | 2170 |
|
|
2022
Q4 | $1.28M | Sell |
23,259
-881
| -4% | -$48.5K | ﹤0.01% | 1946 |
|
|
2022
Q3 | $1.07M | Buy |
24,140
+1,383
| +6% | +$61.2K | ﹤0.01% | 2078 |
|
|
2022
Q2 | $1.11M | Sell |
22,757
-4,422
| -16% | -$216K | ﹤0.01% | 1985 |
|
|
2022
Q1 | $1.32M | Buy |
+27,179
| New | +$1.32M | ﹤0.01% | 2097 |
|